Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Licaminlimab
Other

Licaminlimab

Tracked across 1 events · 6 articles · First seen Jun 08, 2026 · Last active Jun 08, 2026

Sentiment
20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 20
Business
Oculis to Present at Goldman Sachs Conference
Impact: Licaminlimab is a topical anti-TNFa being evaluated by Oculis in a registrational trial for dry eye disease, representing another key product candidate.
Jun 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Licaminlimab live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.